Sustained downregulation of YY1-associated protein-related protein gene expression in rat hippocampus induced by repeated electroconvulsive shock

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 2, 2011, Pages 249-252

  Ohtomo, Takayuki ^a   Kanamatsu, Tomoyuki ^b   Fujita, Mariko ^a   Takagi, Mitsuhiro ^a   Yamada, Junji ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b SOKA UNIVERSITY   (Japan)

Author keywords

Electroconvulsive shock; Hippocampus; Neuron; YY1 associated protein related protein

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG; YY1 ASSOCIATED PROTEIN RELATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ELECTRIC SHOCK; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; TONIC CLONIC SEIZURE; UPREGULATION;

AGE FACTORS; ANIMALS; BLOTTING, NORTHERN; DOWN-REGULATION; ELECTROSHOCK; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; KAINIC ACID; MALE; NEUROGENESIS; RATS; RATS, WISTAR; RNA, MESSENGER; SEIZURES; TRANSCRIPTION FACTORS;

EID: 79551476179     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.249     Document Type: Article

References (33)

1. Ohtomo T., Horii T., Nomizu M., Suga T., Yamada J., Amino Acids, 33, 645-652 (2007).
2. Ohtomo T., Horii T., Nomizu M., Suga T., Yamada J., Amino Acids, 34, 155-161 (2008).
3. Wang C. Y., Liang Y. J., Lin Y. S., Shih H. M., Jou Y. S., Yu W. C., J. Biol. Chem., 279, 17750-17755 (2004).
4. Malberg J. E., Eisch A. J., Nestler E. J., Duman R. S., J. Neurosci., 20, 9104-9110 (2000).
5. Kanamatsu T., McGinty J. F., Mitchell C. L., Hong J. S., J. Neurosci., 6, 644-649 (1986).
6. Kanamatsu T., Obie J., Grimes L., McGinty J. F., Yoshikawa K., Sabol S., Hong J. S., J. Neurosci., 6, 3094-3102 (1986).
7. König J. F. R., Klippel R. A., "The Rat Brain," The Williams and Wilkins Co., Baltimore, 1963.
8. Yamaguchi S., Meguro K., Shimada M., Ishizaki J., Yamadori A., Sekita Y., Neuroradiology, 44, 43-48 (2002).
9. Banasr M., Duman R. S., CNS Neurol. Disord. Drug Targets, 6, 311-320 (2007).
10. Dagyte G., Van der Zee E. A., Postema F., Luiten P. G., Den Boer J. A., Trentani A., Meerlo P., Neuroscience, 162, 904-913 (2009).
11. Cameron H. A., McKay R. D., Nat. Neurosci., 2, 894-897 (1999).
12. Cameron H. A., Gould E., Neuroscience, 61, 203-209 (1994).
13. Eisch A. J., Barrot M., Schad C. A., Self D. W., Nestler E. J., Proc. Natl. Acad. Sci. U.S.A., 97, 7579-7584 (2000).
14. He J., Nixon K., Shetty A. K., Crews F. T., Eur. J. Neurosci., 21, 2711-2720 (2005).
15. Kempermann G., Kuhn H. G., Gage F. H., Nature (London), 386, 493-495 (1997).
16. van Praag H., Christie B. R., Sejnowski T. J., Gage F. H., Proc. Natl. Acad. Sci. U.S.A., 96, 13427-13431 (1999).
17. Shors T. J., Miesegaes G., Beylin A., Zhao M., Rydel T., Gould E., Nature (London), 410, 372-376 (2001).
18. Tanapat P., Hastings N. B., Reeves A. J., Gould E., J. Neurosci., 19, 5792-5801 (1999).
19. Manev H., Uz T., Smalheiser N. R., Manev R., Eur. J. Pharmacol., 411, 67-70 (2001).
20. Chen G., Rajkowska G., Du F., Seraji-Bozorgzad N., Manji H. K., J. Neurochem., 75, 1729-1734 (2000).
21. Madsen T. M., Treschow A., Bengzon J., Bolwig T. G., Lindvall O., Tingstrom A., Biol. Psychiatry, 47, 1043-1049 (2000).
22. Janicak P. G., Davis J. M., Gibbons R. D., Ericksen S., Chang S., Gallagher P., Am. J. Psychiatry, 142, 297-302 (1985).
23. Shen H., Numachi Y., Yoshida S., Fujiyama K., Toda S., Awata S., Matsuoka H., Sato M., Neurosci. Lett., 341, 170-172 (2003).
24. Altar C. A., Laeng P., Jurata L. W., Brockman J. A., Lemire A., Bullard J., Bukhman Y. V., Young T. A., Charles V., Palfreyman M. G., J. Neurosci., 24, 2667-2677 (2004).
25. Altar C. A., Whitehead R. E., Chen R., Wortwein G., Madsen T. M., Biol. Psychiatry, 54, 703-709 (2003).
26. Duman R. S., Vaidya V. A., J. ECT, 14, 181-193 (1998).
27. Nibuya M., Morinobu S., Duman R. S., J. Neurosci., 15, 7539-7547 (1995).
28. Madsen T. M., Yeh D. D., Valentine G. W., Duman R. S., Neuropsychopharmacology, 30, 27-34 (2005).
29. Scott B. W., Wojtowicz J. M., Burnham W. M., Exp. Neurol., 165, 231-236 (2000).
30. Silverstone P. H., Silverstone T., Int. Clin. Psychopharmacol., 19, 113-124 (2004).
31. Nestler E. J., Barrot M., DiLeone R. J., Eisch A. J., Gold S. J., Monteggia L. M., Neuron, 34, 13-25 (2002).
32. Kondratyev A., Sahibzada N., Gale K., Brain Res. Mol. Brain Res., 91, 1-13 (2001).
33. Jiang L., Yao M., Shi J., Shen P., Niu G., Fei J., J. Neurosci. Res., 86, 1209-1216 (2008).